INTRODUCTION
Sapecin is a potent antibacterial protein originally isolated from the culture medium of an embryonic cell line, NIH-Sape-4, derived from Sarcophaga peregrina (flesh fly) [1, 2] . It consists of 40 amino acid residues and has bactericidal activity against various Gram-positive and Gram-negative bacteria, although in general its activity on the latter is lower. It has been shown to have strong affinity for cardiolipin, an acidic phospholipid in bacterial membranes [3] . Its homologues have been found in other dipteran insects [4, 5] . So sapecin seems to constitute a protein family that are the main constituents of the humoral immunity system in many insects [6] .
From 1H-n.m.r. studies, Bontems et al. and other workers have pointed out that charybdotoxin, a toxin acting on K+ channels isolated from the venom of a scorpion, and sapecin share a common structural motif of an a-helix and ,-sheet linked by three intramolecular disulphide bonds [7] [8] [9] . Recently, we isolated two sapecin homologues from a culture medium of NIHSape-4 from which we also isolated sapecin, and found that the molecular mass and amino acid sequence of one of them, named sapecin B, were very similar to those of charybdotoxin [10] .
To determine the active site, if any, of sapecin B, essential for its antibacterial activity, we divided sapecin B into four regions according to the structural model of charybdotoxin [9] and synthesized four amidated peptides corresponding to these regions. We found that one of these peptides, consisting of 11 amino acid residues forming the oc-helix region of sapecin B, showed similar antibacterial activity to that of the intact sapecin B. This a-helical region of sapecin B is probably responsible for the antibacterial activity, while other regions participate in determination of the antibacterial specificity of sapecin B, as this peptide showed a significantly different spectrum of antibacterial activity from that of sapecin B.
MATERIALS AND METHODS Sapecin B and amidated peptides Sapecin B was purified from the culture medium of NIH-Sapeyeasts, including Candida albicans. The peptide was shown to bind to liposomes containing acidic phospholipids and cause release of entrapped glucose, suggesting that its primary site of action is the bacterial membrane. Its antimicrobial activity could be increased by substituting various amino acid residues for hydrophobic and/or basic ones. 4 cells as described previously [10] . Amidated peptides were synthesized using the solid-phase method in a peptide synthesizer (Applied Biosystems, model 430A). Each peptide was purified to homogeneity by h.p.l.c. using a reverse-phase column of Synchropak RP-R (C18) and its amino acid sequence was confirmed using a protein sequencer (Applied Biosystems, model 477A).
Assay of antimicrobial activity
Antimicrobial activity against bacteria was assayed as described previously using Staphylococcus aureus ATCC 65388P and Escherichia coli K-12 594 as indicator bacteria [1] Identification of free thiol groups in the 7R-17K fragment of sapecin B For determination of whether the two cysteine residues in the 7R-17K fragment form a disulphide bridge, the reactivities of the peptide with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) before and after its reduction were compared according to the method of Ellman [11] . Briefly, samples of less than 5 nmol of the peptide were treated in 1 M NaBH4 solution, or water containing 0.1 M NaOH and 20 mM EDTA, for 1 h at 37 'C. Then [12] . Briefly, a single phospholipid or a mixture of phospholipids was dissolved in chloroform, and an aliquot containing 1 ,umol of phospholipids was dried completely in a rotary evaporator under reduced pressure. Then 0.1 ml of 0.3 M glucose solution was added and the lipids were dispersed with the aid of a vortex mixer to obtain multilamellar liposomes containing glucose. The liposomes were then washed twice with 0.4 ml of 5 mM Veronal buffer, pH 7.5, containing 0.15 M NaCl (Veronal-buffered saline) to remove untrapped glucose, and finally suspended in 0.5 ml of the same buffer.
In tests on the sensitivity of liposomes to peptides, various concentrations of the peptides dissolved in 10 ul of 10 mM phosphate buffer, pH 6.0, containing 130 mM NaCl were added to 10 ,ul of the liposome suspension. The mixtures were incubated at 37°C for 30 min and then the amount of released glucose was determined [13] . Phospholipids in the liposomes were measured by determining the amount of phosphate by the method of Chen et al. [14] . Glucose released from the liposomes was measured with a Glucose C-Test kit (Wako Chemical Co., Japan), consisting ofphenol, 4-aminoantipyrine, mutarotase, glucose oxidase and peroxidase. A red-coloured quinone derivative was formed with phenol and 4-aminoantipyrine in the presence of glucose, and from the absorbance at 492 nm of this compound, the amount of glucose in the reaction mixture was determined [3] . Fluorescence-labeiiing of the 71-17K fragment with mBBr Fluorescence-labelling of the 7R-17K fragment was performed by modifying its cysteine residues with mBBr by the method of Fahey et al. [15] . Briefly, 0.1 ,umol of the 7R-17K fragment was dissolved in 40,1 of Hepes/HCl (pH 8.0) containing 5 mM diethylenetriamine-NNN'N"N"-penta-acetic acid and 2 mM mBBr, and kept in the dark for 10 min at room temperature to allow the reaction to proceed. Then 2 ,1 of methanesulphonic acid was added to terminate the reaction and the resulting mBBrlabelled 7R-1 7K fragment was purified by h.p.l.c. in a Packed sheep erythrocytes (0.2 ml) were washed three times with 0.8 ml of PBS (130 mM NaCl, 3 mM KC1, 8 mM Na2HPO4, 1.5 mM KH2PO4) by repeating centrifugation at 2000 g for 5 min, and were resuspended in 10 ml of the same PBS solution. The resulting erythrocyte suspension (25 ,ul) and sample solution (251,) containing various concentrations of the peptides were mixed and incubated at 37°C for 2 h. After centrifugation at 2000 g for 5 min, the A576 values of the supernatants were measured. Melittin (Boehringer-Mannheim) was used as a positive control.
RESULTS
Preparation of four fragments of sapecin B and their antibacterial activities From structural comparison of sapecin B and charybdotoxin, amino acid residues 7-17 of sapecin B were expected to form a helical structure and residues 29-34 to form a sheet structure in solution. We synthesized four peptides corresponding to amino acid residues 1-6, 7-17, 18-28 and 29-34 of sapecin B having amidated amino acid residues at their C-terminal, as shown in Figure 1 , and examined their antibacterial activities against S. aureus. Only the 7R-17K fragment (amino acid residues 7-17 of sapecin B) repressed the growth of S. aureus, its antibacterial activity being almost comparable with that of sapecin B: their ID50 values (concentrations for 500% growth inhibition) being 0.7-1.5 ,tM. The three other peptides had essentially no antibacterial activity at concentrations less than 10 ,uM ( Figure 2 ). These results suggested that the amino acid sequence of residues 7-17 of sapecin B is important for its antibacterial activity.
As reported previously, sapecin B is toxic to Gram-positive bacteria such as S. aureus, but its antibacterial effect on Gramnegative bacteria such as E. coli is not so marked [10] . However, as summarized in Table 1 , the 7R-17K fragment repressed the growth of E. coli, as well as that of S. aureus. Surprisingly, this fragment also repressed the growth of a fungus, Candida albicans, 29V-340 fragment. although the ID50 value of this activity was one order of magnitude higher than that of its antibacterial activity.
To determine whether the growth inhibition of C. albicans by the 7R-17K fragment is due to a fungicidal effect or simply a fungistatic effect, we counted viable cells. For this, a fixed number of C. albicans cells were treated with increasing amounts of the 7R-17K fragment for 1 h and then plated. As shown in Figure 3 , numbers of colonies decreased markedly with increases in the peptide concentration, indicating that this peptide has fungicidal activity. We also found that the viable numbers of S. aureus and E. coli cells decreased drastically from 2 x 105 to 2 x 102 on their treatment with 10,uM of this peptide. Thus, the 7R-17K fragment seems to be toxic to various micro-organisms, and kills at least the two bacteria and one fungus so far tested.
Interaction of the 7R-17K fragment with phospholipids Previously, we have found that sapecin interacts with cardiolipin (CL) in bacterial membranes and that the susceptibilities of bacteria to sapecin partly depend on their content of this phospholipid [3] . Therefore, we examined whether the 7R-17K fragment interacted with bacterial phospholipids. A fluorescencelabelled 7R-17K fragment was necessary for this experiment, so we first examined whether the two thiol groups in the 7R-17K fragment are free or form a disulphide bridge. For this, we compared the reactivity of this fragment with DTNB with and without reduction with NaBH4. The reactivity of this fragment with DTNB was not affected by its reduction, and was twice that of reduced glutathione on a molar basis, indicating that the two thiol groups in the 7R-17K fragment are free. Therefore, we labelled this fragment with mBBr, which reacts with free thiol groups in a peptide, and purified the resulting labelled 7R-17K fragment to homogeneity using h.p.l.c. The labelled fragment showed no reactivity with DTNB, indicating that its two thiol groups were labelled with mBBr. This was confirmed by sequencing the labelled peptide.
We examined the binding of labelled 7R-17K fragment to phospholipids. Liposomes were prepared by mixing phosphatidylcholine (PtdCho) and various other phospholipids in molar ratios of 0.6 to 0.4. A fixed amount of the labelled 7R-17K fragment was incubated with increasing amounts of liposomes, the liposomes were then washed well, and the amount of bound peptide was measured by fluorescence spectrophotometry. mBBr itself had no affinity for any of the liposomes used, so the fluorescence detected was due to the bound 7R-17K fragment. As shown in Figure 4 , significant binding was detected with all acidic phospholipids except phosphatidylserine (PtdSer). These results indicate that the binding specificity of this peptide is not so strict as that of sapecin, which binds exclusively to CL, but the binding efficiency to CL was higher than those to phosphatidylinositol (Ptdlns) and phosphatidylglycerol (PtdGly). The fragment showed no significant binding to neutral phospholipids such as phosphatidylethanolamine (PtdEtn) and PtdCho.
As reported previously, E. coli is less sensitive than S. aureus to sapecins; this is partly explained by the difference in their membrane contents of CL [1, 3, 10] . However, as the 7R-17K fragment of sapecin B was active against both S. aureus and E. coli and bound to various acidic phospholipids, we examined whether it disrupted liposomes. For this, we prepared two types of liposomes with similar phospholipid compositions to those of the membranes of S. aureus and E. coli respectively, each containing trapped glucose, and examined the effects of the 7R-17K fragment and sapecin B on them by measuring the release of this glucose. As shown in Figure 5 , an increase in the Antibacterial activities of analogues of the 7R-17K fragment The above results showed that the 7R-17K fragment of sapecin B had antimicrobial activity, and that this activity seemed to be due to its interaction with acidic phospholipids in bacterialmembranes. As this fragment presumably interacts with bacterial membranes via its hydrophobic amino acid residues and/or positively charged amino acid residues, we thought that its antibacterial activity might be increased by changing these aminot acid residues. To test this possibility, we synthesized four' analogues of this peptide and examined their antibacterial activities. Analogue 1 was essentially the same as the 7R-17K Table 3 Surface activities of antimicrobial peptides Peptides or SDS were dissolved in distilled water at concentrations of 0.154 mM. Surface tensions were measured in a platinum ring connected to a precision electrobalance at 25 OC by the method of Harkins and Jordan [16] .
Sample
Surface tension (10- Figure 6 Haemolytic activities of antmicrobial peptides Sheep erythrocytes were incubated with increasing amounts of each peptide for 2 h at 37°C. After centrifugation, the A576 values of the resulting supernatants were measured. Complete lysis was achieved by incubating the cells in distilled water. The peptides used were: C1. analogue 1; V. analogue 2; A, analogue 3; 0, analogue 4; O, the 7R-17K fragment; *, melittin (positive control). fragment except that the C-terminal lysine was not amidated. In analogue 2, the two cysteine residues of the 7R-17K fragment were replaced by leucine residues to increase hydrophobicity. In analogue 3, the third leucine residue was replaced by lysine to increase electropositivity in the N-terminal region, and the second serine and seventh histidine residues were replaced by leucine residues to increase hydrophobicity. Analogue 4 was the same as analogue 3 except that its C-terminal lysine was not amidated.
As shown in Table 2 , the antibacterial activities of analogues 2 and 3 against S. aureus were 5-7-fold greater than that of the 7R-17K fragment. However, their antibacterial activities against E. coli were at most twice that of the original peptide. Judging from the activities of the 7R-17K fragment and analogue 1, amidation of the C-terminal lysine residue of the peptide seemed to increase the activity. A similar tendency was observed with analogues 3 and 4.
As these peptides are supposed to interact with bacterial membranes, they are expected to have high surface activity. To confirm this, we measured the surface tensions of the peptide solutions at concentrations of 0.154 mM by the method of Harkins and Jordan [16] . These solutions had lower surface tensions than that of SDS solution, as shown in Table 3 , and a good correlation was observed between the surface tension and antibacterial activity (cf. Table 2 ).
As the 7R-17K fragment had antifungal activity against C. albicans, we examined the effects of these analogues on various fungi. For this, we determined the minimum inhibitory concentration of each peptide. As summarized in Table 4 , all these peptides significantly inhibited growth of the fungi tested, but the antifungal activities of analogues 2 and 3 were higher than those of other peptides. In particular, their antifungal activities against C. albicans were 4-8-fold greater than that of the 7R-17K fragment. Of these fungi, Rhodotorula glutinis was especially sensitive to these peptides, the minimum inhibitory concentration being below 3,M. Peptides having much higher antibacterial and/or antifungal activity could probably be designed on the basis of these results.
As these peptides are surface-active and repress the growth of bacteria and fungi, we thought that they could also be effective on mammalian cells. To test this possibility, we examined their haemolytic activities on sheep erythrocytes. Contrary to expectation, no appreciable haemolytic activity was detected under conditions in which melittin caused significant haemolysis ( Figure  6 ). Thus, these peptides are probably not so effective on mammalian cells despite having potent antimicrobial activity.
DISCUSSION
Several antibacterial proteins have been isolated from various insects and characterized [17] [18] [19] [20] [21] [22] [23] . The primary targets of most of these proteins are thought to be the bacterial membrane. In fact, we demonstrated that sarcotoxin I (a cecropin-type antibacterial protein of Sarcophaga) has ionophore activity, causing loss of the membrane potential of E. coli [24] . We also demonstrated that sapecin specifically interacts with CL in bacterial membranes [3] . Several attempts have been made to modify the activities of these proteins. A hybrid analogue of cecropin A and D, and the D-enantiomers of cecropin A, magainin-2-amide and melittin were synthesized chemically [25, 26] . Cecropin-melittin hybrids were also synthesized [27] . Rosenthal et al. substituted arginine residues in diptericins by canavanine, an arginine antagonist [28] . However, there are no reports of fragmentation of a known antibacterial protein to identify its active site.
In this study, we synthesized four amidated peptides which together constitute the whole of sapecin B, and found that one peptide corresponding to the helix region of sapecin B, as judged by analogy to charybdotoxin, had potent antibacterial activity. The antibacterial activity of this hendecapeptide against S. aureus was almost comparable with that of intact sapecin B. However, unlike sapecin B, this peptide also showed antimicrobial activity against E. coli and various yeasts including C. albicans. This finding suggests two possibilities: one is that the 7R-17K fragment is the active site of sapecin B and so sapecin B is potentially toxic to both Gram-positive and Gram-negative bacteria, and also to fungi, but that its other regions interfere with the interaction with Gram-negative bacteria and/or fungi, and so it shows antibacterial activity only against Gram-positive bacteria. The other possibility is that sapecin B is active as a complete molecule, but that the 7R-17K fragment incidentally shows antimicrobial activity, so the antimicrobial activities of intact sapecin B and this peptide are independent. At present, it is difficult to know which possibility is correct, as the antimicrobial specificities of the two substances are different. On treatment of S. aureus-membrane-type liposomes with the 7R-17K peptide or sapecin B, entrapped glucose was released. The concentrations of the peptide causing liposome disruption and inhibiting bacterial growth were almost the same. However, the concentration of sapecin B causing liposome disruption was higher than that inhibiting bacterial growth. These facts support the latter possibility. If the former possibility is correct, it may be possible to identify the active sites of other antibacterial proteins such as sarcotoxin I in the same way.
It is noteworthy that the 7R-17K fragment showed antifungal activity as well as antibacterial activity. Several groups have reported isolations of small antibacterial peptides from various organisms: tachyplesin (17 amino acid residues) [29] , indolicidin (13 amino acid residues) [30] and bactenecin (12 amino acid residues) [31] . However, none ofthese peptides showed antifungal activity. Small peptides having potent antifungal activity such as the 7K-17R fragment may be potentially important as lead compounds to design better antifungal agents.
We showed that the antimicrobial activity of the 7R-17K fragment could be increased by changing a few of its amino acid residues. For this, we synthesized analogues of this peptide with reference to hydrophobic and positively charged amino acid residues. We found a correlation between the antibacterial activities and surface activities of these peptides. As their surface activities were due to their amphipathic characters, the amphipathicities of these peptides seemed to be related to their antibacterial activities. We also found that amidated peptides had higher activity than non-amidated ones. Probably, amidated peptides are more resistant to microbial proteinases than nonamidated ones and this may explain their higher activities.
